Angelika M. Dräger

1.5k citations

22 papers · 784 indexed · h-index 13

Hematology top 5%
- Platelet Disorders and Treatments 5
- Acute Myeloid Leukemia Research 4
- Hematopoietic Stem Cell Transplantation 4
Immunology and Allergy top 5%
- Cell Adhesion Molecules Research 6
Immunology top 10%
- Immunotherapy and Immune Responses 5
Genetics top 10%
Cell Biology top 10%
- Proteoglycans and glycosaminoglycans research 7
Molecular Biology
- Glycosylation and Glycoproteins Research 5
Oncology
- Chemokine receptors and signaling 4

Co-authors: Peter C. Huijgens Floortje L. Kessler Lex Nagelkerken Sonja Zweegman Arjan A. van de Loosdrecht Jacob van den Born Gert J. Ossenkoppele August H. Westra
Cited by: Hematology Immunology and Allergy Immunology
Journals: Journal of Biological Chemistry (1 paper)Blood (1 paper)Journal of Cell Science (1 paper)
Partner nations: Netherlands Finland United States

In The Last Decade

Angelika M. Dräger

22 papers receiving 769 citations

Peers

Countries citing papers authored by Angelika M. Dräger

Since Specialization

Citations

This map shows the geographic impact of Angelika M. Dräger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angelika M. Dräger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angelika M. Dräger more than expected).

Fields of papers citing papers by Angelika M. Dräger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angelika M. Dräger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angelika M. Dräger. The network helps show where Angelika M. Dräger may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Angelika M. Dräger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Angelika M. Dräger Line = papers co-authored together Angelika M. Dräger links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Subendothelial Heparan Sulfate Proteoglycans Become Major L-Selectin and Monocyte Chemoattractant Protein-1 Ligands upon Renal Ischemia/Reperfusion American Journal Of Pathology ·Johanna W.A.M. Celie,Niels W. Rutjes,Eelco D. Keuning,Raija Soininen,Ritva Heljäsvaara,Taina Pihlajaniemi,Angelika M. Dräger,Sonja Zweegman,Floortje L. Kessler,Robert H.J. Beelen,Sandrine Florquin,Jan Aten,Jacob van den Born	2007	66
2	Reduced supportive capacity of bone marrow stroma upon chemotherapy is mediated via changes in glycosaminoglycan profile Matrix Biology ·Sonja Zweegman,Floortje L. Kessler,Ron Kerkhoven,Mike Heimerikx,Johanna W.A.M. Celie,Jeroen J. W. M. Janssen,Peter C. Huijgens,Angelika M. Dräger,Jacob van den Born	2007	8
3	Identification of distinct prognostic subgroups in low- and intermediate-1–risk myelodysplastic syndromes by flow cytometry Blood ·Arjan A. van de Loosdrecht,Theresia M. Westers,August H. Westra,Angelika M. Dräger,Vincent H. J. van der Velden,Gert J. Ossenkoppele	2007	146
4	Synaptotagmin 3 deficiency in T cells impairs recycling of the chemokine receptor CXCR4 and thereby inhibits CXCL12 chemokine-induced migration Journal of Cell Science ·Agnieszka Masztalerz,Ingrid S. Zeelenberg,Yvonne M. Wijnands,Rosalie de Bruijn,Angelika M. Dräger,Hans Janssen,Ed Roos	2006	19
5	Identification of L-selectin Binding Heparan Sulfates Attached to Collagen Type XVIII Journal of Biological Chemistry ·Johanna W.A.M. Celie,Eelco D. Keuning,Robert H.J. Beelen,Angelika M. Dräger,Sonja Zweegman,Floortje L. Kessler,Raija Soininen,Jacob van den Born	2005	32
6	Integrin α4β1 involvement in stromal cell-derived factor-1α-promoted myeloma cell transendothelial migration and adhesion: role of cAMP and the actin cytoskeleton in adhesion Experimental Cell Research ·Marisa Parmo‐Cabañas,Rubén A. Bartolomé,Natalia Wright,Andrés Hidalgo,Angelika M. Dräger,Joaquı́n Teixidó	2004	62
7	Bone marrow stromal proteoglycans regulate megakaryocytic differentiation of human progenitor cells Experimental Cell Research ·Sonja Zweegman,J van den Born,Adriana M. C. Mus,Floortje L. Kessler,Jeroen J. W. M. Janssen,Tanja Netelenbos,Peter C. Huijgens,Angelika M. Dräger	2004	13
8	In vitro model for hematopoietic progenitor cell homing reveals endothelial heparan sulfate proteoglycans as direct adhesive ligands Journal of Leukocyte Biology ·Tanja Netelenbos,Jacob van den Born,Floortje L. Kessler,Sonja Zweegman,Peter C. Huijgens,Angelika M. Dräger	2003	24
9	Early Apoptosis Largely Accounts for Functional Impairment of CD34 ⁺ Cells in Frozen-Thawed Stem Cell Grafts Journal of Hematotherapy & Stem Cell Research ·Fransien de Boer,Angelika M. Dräger,Herbert M. Pinedo,Floortje L. Kessler,M. Monnee-van Muijen,G W D Weijers,Guus Westra,Elsken van der Wall,Tanja Netelenbos,Jan W. Oberink,Peter C. Huijgens,Gerrit Jan Schuurhuis	2002	52
10	Granulocyte colony‐stimulating factor mobilized whole blood containing over 0·3 × 10⁶/kg CD34⁺ cells is a sufficient graft in autologous transplantation for relapsed non‐Hodgkin's lymphoma British Journal of Haematology ·Andries R. Jonkhoff,Arne M. De Kreuk,Gaby Franschman,J. van der Lelie,Gerrit Jan Schuurhuis,Angelika M. Dräger,Sonja Zweegman,Peter C. Huijgens,Gert J. Ossenkoppele	2002	6
11	Homing and clonogenic outgrowth of CD34+ peripheral blood stem cells Experimental Hematology ·Fransien de Boer,Floortje L. Kessler,Tanja Netelenbos,Sonja Zweegman,Peter C. Huijgens,Elsken van der Wall,J.A.M. van der Linden,Herbert M. Pinedo,Gerrit Jan Schuurhuis,Angelika M. Dräger	2002	9
12	Proteoglycans guide SDF-1-induced migration of hematopoietic progenitor cells Journal of Leukocyte Biology ·Tanja Netelenbos,Suzanne Zuijderduijn,Jacob van den Born,Floortje L. Kessler,Sonja Zweegman,Peter C. Huijgens,Angelika M. Dräger	2002	82
13	Differences in sulfation patterns of heparan sulfate derived from human bone marrow and umbilical vein endothelial cells Experimental Hematology ·Tanja Netelenbos,Angelika M. Dräger,Bert van het Hof,Floortje L. Kessler,Claude Delouis,Peter C. Huijgens,Jacob van den Born,Willem van Dijk	2001	38
14	Regulation of megakaryocytopoiesis in an in vitro stroma model Experimental Hematology ·Sonja Zweegman,M. Veenhof,Peter C. Huijgens,Gerrit-Jan Schuurhuis,Angelika M. Dräger	2000	31
15	Cell Cycle Dependency of Gallium Uptake and Cytotoxicity in Human Cell Lines of Hematological Malignancies Leukemia & lymphoma ·E. Adrianna Van Leeuwen-Stok,Andries R. Jonkhoff,Angélique W.J. Visser-Platier,Angelika M. Dräger,G. J. J. Teule,Peter C. Huijgens,Gerrit Jan Schuurhuis	1998	9
16	Heterogenous effects of bryostatin on human myeloid leukemia clonogenicity: Dose and time scheduling dependency Leukemia Research ·K.G. van der Hem,Gerrit Jan Schuurhuis,Angelika M. Dräger,Joan H. Odding,Peter C. Huijgens	1996	2
17	Radiotoxicity of 67-Gallium on myeloid leukemic blasts Leukemia Research ·Andries R. Jonkhoff,Peter C. Huijgens,Richard T. Versteegh,Arthur van Lingen,G. J. Ossenkoppele,Angelika M. Dräger,G. J. J. Teule	1995	12
18	Effects of bryostatin-5 and hematopoietic growth factors on acute myeloid leukemia cell differentiation, proliferation, and primary plating efficiency Leukemia Research ·K.G. van der Hem,Angelika M. Dräger,Joan H. Odding,Peter C. Huijgens	1995	4
19	Bryostatin-5 stimulates normal human hematopoiesis and inhibits proliferation of HL60 leukemic cells Leukemia Research ·K.G. van der Hem,Angelika M. Dräger,Joan H. Odding,M. M. A. C. Langenhuijsen,Peter C. Huijgens	1995	7
20	Biological effectiveness of 67-gallium decay in HL60 cells compared with external low dose rate gamma irradiation: Effects on proliferation, G2 arrest, and clonogenic capacity International Journal of Radiation OncologyBiologyPhysics ·Andries R. Jonkhoff,E.B. van Dieren,Peter C. Huijgens,Richard T. Versteegh,Angelika M. Dräger,Arjan A. van de Loosdrecht,G. J. J. Teule	1994	10

About Angelika M. Dräger

Angelika M. Dräger is a scholar working on Hematology, Immunology and Allergy and Cell Biology, having authored 22 papers that have together received 784 indexed citations. Recurring topics across this work include Proteoglycans and glycosaminoglycans research (7 papers), Cell Adhesion Molecules Research (6 papers), Glycosylation and Glycoproteins Research (5 papers), Platelet Disorders and Treatments (5 papers), Immunotherapy and Immune Responses (5 papers), Acute Myeloid Leukemia Research (4 papers), Hematopoietic Stem Cell Transplantation (4 papers) and Chemokine receptors and signaling (4 papers). The work is most often cited by research in Hematology (323 citations), Immunology and Allergy (109 citations) and Immunology (261 citations). Angelika M. Dräger has collaborated with scholars based in Netherlands, Finland and United States. Frequent co-authors include Peter C. Huijgens, Floortje L. Kessler, Lex Nagelkerken, Sonja Zweegman, Arjan A. van de Loosdrecht, Jacob van den Born, Gert J. Ossenkoppele, August H. Westra, Theresia M. Westers and Vincent H. J. van der Velden. Their work appears in journals such as Journal of Biological Chemistry, Blood and Journal of Cell Science.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact